EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C07K PEPTIDES 2134
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2008/0279,850 B-Cell Reduction Using CD37-Specific and CD20-Specific Binding MoleculesApr 11, 08Nov 13, 08[A61K, C12P, C12N, A61P, C07K]

Recent Patents

  • No Recent Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0154,250 SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTIONAbandonedMar 15, 13Jun 05, 14[C07K]
2014/0154,252 SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTIONAbandonedMar 15, 13Jun 05, 14[C07K]
2014/0127,203 SINGLE-CHAIN MULTIVALENT BINDING PROTEINS EFFECTOR FUNCTIONAbandonedMar 15, 13May 08, 14[C07K]
2014/0072,562 B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULESAbandonedMar 15, 13Mar 13, 14[A61K]
8632774 Antagonists of IL-6ExpiredJul 02, 09Jan 21, 14[A61K]
2013/0336,977 SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTIONAbandonedMay 31, 13Dec 19, 13[C07K]
2013/0323,233 MATERIALS AND METHODS FOR IMPROVED IMMUNOGLYCOPROTEINSAbandonedDec 21, 12Dec 05, 13[C07K]
2013/0280,240 Materials and Methods for Improved ImmunoglycoproteinsAbandonedJun 14, 13Oct 24, 13[C07K]
2013/0195,850 CD3 IMMUNOTHERAPEUTICS AND USES THEREOFAbandonedNov 15, 12Aug 01, 13[C07K]
2013/0189,261 TCR Complex ImmunotherapeuticsAbandonedMar 14, 13Jul 25, 13[A61K, C07K]
2013/0129,723 Heterodimer Binding Proteins and Uses ThereofAbandonedDec 29, 10May 23, 13[C07K]
2013/0095,097 Polypeptide Heterodimers and Uses ThereofAbandonedDec 29, 10Apr 18, 13[C07K]
2013/0089,554 RON Binding Constructs and Methods of Use ThereofAbandonedDec 29, 10Apr 11, 13[C07K]
2013/0052,195 Compositions Comprising TNF-alpha and IL-6 Antagonists and Methods of Use ThereofAbandonedDec 23, 10Feb 28, 13[A61K, A61P]
2011/0223,164 BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINSAbandonedMar 02, 11Sep 15, 11[A61K, A61P]
2011/0217,302 TCR Complex ImmunotherapeuticsAbandonedOct 09, 09Sep 08, 11[A61K, C07H, C12N, G01N, A61P, C07K]
2011/0177,070 TGF-Beta Antagonist Multi-Target Binding ProteinsAbandonedJul 02, 09Jul 21, 11[A61K, C07H, C12P, C12N, A61P, C07K]
2011/0158,995 Multi-Specific Binding Proteins Targeting B Cell DisordersAbandonedJul 28, 09Jun 30, 11[A61K, C07H, C12P, C12N, A61P, C07K]
2011/0152,173 TNF-a ANTAGONIST MULTI-TARGET BINDING PROTEINSAbandonedJul 02, 09Jun 23, 11[A61K, C07H, C12P, C12N, A61P, C07K]
2010/0330,089 ANTI-CD20 THERAPEUTIC COMPOSITIONS AND METHODSAbandonedJun 12, 08Dec 30, 10[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.